Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Rheumatoid Arthritis

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 7 articles:
HTML format



Single Articles


    January 2022
  1. SARAUX A, Devauchelle-Pensec V
    Primary Sjogren's syndrome: new beginning for evidence-based trials.
    Lancet. 2022;399:121-122.
    PubMed    


  2. BOWMAN SJ, Fox R, Dorner T, Mariette X, et al
    Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjogren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.
    Lancet. 2022;399:161-171.
    PubMed     Abstract available


    August 2021
  3. MCLORNAN DP, Pope JE, Gotlib J, Harrison CN, et al
    Current and future status of JAK inhibitors.
    Lancet. 2021;398:803-816.
    PubMed     Abstract available


    January 2021
  4. HUMBY F, Durez P, Buch MH, Lewis MJ, et al
    Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial.
    Lancet. 2021;397:305-317.
    PubMed     Abstract available


  5. PODDUBNYY D
    Precision medicine in rheumatology: are we getting closer?
    Lancet. 2021;397:258-259.
    PubMed    


    July 2020
  6. BURMESTER GR, Buttgereit F, Bernasconi C, Alvaro-Gracia JM, et al
    Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial.
    Lancet. 2020;396:267-276.
    PubMed     Abstract available


  7. VOLKMANN ER
    Tapering glucocorticoids in rheumatoid arthritis.
    Lancet. 2020;396:218-219.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: